CD8A and melanoma: When combined with a prime-boost vaccination regimen with the melanoma TAA Trp1, containing two palmitic acid chains to augment the peptide’s immunogenicity, or with natural Trp2 peptide, Poly-IC enhanced the frequency of mouse antigen-specific CD8+ T cells and was more effective than CpG.